Immupharma (IMM) Short Positions
Add to Alert list

Active Short Positions

Holder Position Change Date
No active short positions

Historical Short Positions

Holder Position Change (%) Date
WorldQuant LLC 0.47% 12-Mar-2018 View History
WorldQuant LLC 0.5% 05-Mar-2018 View History
WorldQuant LLC 0.49% 22-Feb-2018 View History
WorldQuant LLC 0.5% 21-Feb-2018 View History
WorldQuant LLC 0.49% 19-Feb-2018 View History
WorldQuant LLC 0.51% 14-Feb-2018 View History
Darwin Strategic Limited 0% 14-Oct-2013 View History
Darwin Strategic Limited 0.91% 08-Oct-2013 View History
Darwin Strategic Limited 0.87% 03-Oct-2013 View History
Darwin Strategic Limited 0.94% 01-Oct-2013 View History
Darwin Strategic Limited 1.04% 27-Sep-2013 View History
Darwin Strategic Limited 0.76% 25-Sep-2013 View History
Darwin Strategic Limited 0.6% 24-Sep-2013 View History
Darwin Strategic Limited 0.54% 23-Sep-2013 View History

ImmuPharma is a pharma company headquartered in London with its research R&D team, ImmuPharma Biotech, based in France. 

ImmuPharma listed on AIM under the ticker IMM. 

IMM research strategy is based on two strategic axes: research based on external collaboration aimed at discovering new active ingredients, which has led to the development of our most advanced project in terms of clinical development: P140 an active peptide against the auto-immune disease, Lupus SLE and internal research based on the use of molecular programming technologies, which has notably led to the development of the BioAMB and BioCIN projects.

IMM share price listed in London at 1,190p in 2000. 

Note: This description is in part generated by AI and not an endorsement by or the opinion of Investegate
Investor Meets Company
UK 100

Latest directors dealings